For the Inventor, By the Inventor

Enter assignee name

Barcelona, Spain

Esteve Pharmaceuticals, S.a.

USPTO Granted Patents = 34

% Expired Patents = 50.0

CIPO Patents = 6

EPO Patents = 27

Trademarks = 6

Forward Citations = 6

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Carmen Almansa-Rosales (24 out of 37 patents)

Marina Virgili-Bernado (9 out of 10 patents)

Carlos Alegret-Molina (7 out of 9 patents)

4. Félix Cuevas-Cordobés (5 out of 9 patents)

5. Monica Garcia-Lopez (5 out of 10 patents)

6. Monica Alonso-Xalma (4 out of 5 patents)

7. Nicolas Tesson (3 out of 21 patents)

8. Ute Christmann (3 out of 6 patents)

9. Monica Garcia Lopez (3 out of 9 patents)

10. Antoni Torrens-Jover (3 out of 9 patents)

11. Albert Ribera Sanchez (2 out of 2 patents)

12. Ana Virginia Llorente-Fernandez (2 out of 3 patents)

13. Ana-Maria Caamaño-Moure (2 out of 2 patents)

14. José-Luís Díaz-Fernández (2 out of 3 patents)

15. Ariadna Fernandez-donis (2 out of 2 patents)

Core Competencies:

Pain Management

Adenoassociated Virus Vectors

Oxadiazaspiro Compounds

Pyrazolo Derivatives

Quinazolin Derivatives

HIV-1 Treatment

Mucopolysaccharidoses

Drug Addiction

Tramadol Co-Crystals

Piperazine Derivatives

Multimodal Activity

Lysosomal Storage Disorders

34 patents: Sort by Forward Citations

1. 12617797 - Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain (2026-05-05),

2. 12479830 - Homopiperazinyl and homopiperidinyl quinazolin-4(3H)-one derivatives having multimodal activity against pain (2025-11-25),

3. 12398403 - Methods for the manufacture of recombinant viral vectors (2025-08-26),

4. 12201095 - Animal model of mucopolysaccharidoses type IVA (2025-01-21),

5. 12146169 - Adenoassociated virus vectors for the treatment of mucopolysaccharidoses type IV A (2024-11-19),

6. 11919926 - Method of treating HIV-1 infection utilizing a multiepitope T cell immunogen comprising Gag, Pol, Vif, and Nef epitopes (2024-03-05),

7. 11649248 - Oxadiazaspiro compounds for the treatment of drug abuse and addiction (2023-05-16),

8. 11478488 - Co-crystals of tramadol and coxibs (2022-10-25),

9. 11401270 - Alcoxyamino derivatives for treating pain and pain related conditions (2022-08-02),

10. 11338046 - Adenoassociated virus vectors for the treatment of mucopolysaccharidoses (2022-05-24),

11. 11236110 - Salts of (R)-9-(2,5-difluorophenethyl)-4-ethyl-2-methyl-1-oxa-4,9-diazaspiro[5.5]undecan-3-one (2022-02-01),

12. 11149285 - Adenoassociated virus vectors for the treatment of lysosomal storage disorders (2021-10-19),

13. 11111220 - Propanamine derivatives for treating pain and pain related conditions (2021-09-07),

14. 10941138 - Quinoline and isoquinoline derivatives for treating pain and pain related conditions (2021-03-09),

15. 10927128 - Oxadiazaspiro compounds for the treatment of drug abuse and addiction (2021-02-23),

Company Overview

Esteve Pharmaceuticals, based in Barcelona, specializes in the development and manufacturing of innovative pharmaceutical products. The company focuses on therapeutic areas such as pain management, respiratory diseases, and central nervous system disorders. Esteve is committed to advancing healthcare through research and development, leveraging cutting-edge technologies to create effective solutions for patients. Its dedication to quality and innovation positions it as a key player in the pharmaceutical industry, particularly within the European market.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

34 Patents

#18 in Barcelona

#49 in Spain

#19,651 in the World

Barcelona, Spain

Esteve Pharmaceuticals, S.a.

Forward Citations = 6

54 inventors:

Carmen Almansa-Rosales (24 out of 37 patents)

Marina Virgili-Bernado (9 out of 10 patents)

Carlos Alegret-Molina (7 out of 9 patents)

4. Félix Cuevas-Cordobés (5 out of 9 patents)

5. Monica Garcia-Lopez (5 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Esteve Pharmaceuticals, S.a.. Retrieved from https://idiyas.com/company/esteve-pharmaceuticals-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…